In recognition of Lung Cancer Awareness Month, Massachusetts General Hospital physicians answer common questions related to lung cancer.
Jennifer Temel, MD
Jennifer Temel, MD
Co-Director, Cancer Outcomes Research and Education Program
Professor of Medicine at Harvard Medical School
Departments, Centers, & Programs:
Mass General Cancer Center: Hematology Oncology
55 Fruit St.
Boston, MA 02114
- MD, Washington University
- Residency, Brigham and Women's Hospital
- Fellowship, Dana Farber Cancer Institute
American Board Certifications
- Medical Oncology, American Board of Internal Medicine
Accepted Insurance Plans
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Temel’s research focuses on palliative care, symptom management, and patient-clinician communication. She has studied novel care models of providing palliative care to patients with advanced cancer, including the early involvement of palliative care in the ambulatory care setting. Dr. Temel’s paradigm changing research in this area was published in the New England Journal of Medicine and the Journal of Clinical Oncology. As a thoracic oncologist, she has a longstanding interest in improving both physical and psychological symptom in patients with lung and esophageal cancer. She has conducted numerous trials aimed at improving physical function, fatigue, quality of life, mood, and shortness of breath in patients with advanced cancer.
Dr. Temel is also interested in enhancing patient-clinician communication about the goals of cancer treatment and patients’ preferences for care at the end of life. She has conducted several trials focused on improving patients’ understanding of their prognosis and patient-clinician communication about end of life care.
Her future goals are to continue to develop innovative interventions to improve communication between patients and their families and their oncology clinicians. Dr. Temel is also interested in mentoring students, trainees, and junior faculty and has two National Cancer Institute grants to support her efforts training others in palliative care and supportive care research.
Related News and Articles
- Sep | 1 | 2013
Research demonstrates that for advanced lung cancer patients, offering early palliative care on an outpatient or ambulatory basis complements standard oncology and leads to longer survival time
- Feb | 10 | 2021
Translational research helps move new ideas and treatments from the lab to the clinic. Supportive care research strives to improve the experience and outcomes of patients and caregivers across the continuum of cancer care. Learn about the latest, cutting-edge advances in this webinar.
- Jan | 1 | 2020
Palliative Care Paradigm Shift and the Future of Patient-focused Innovations with Jennifer Temel, MD
Jennifer Temel, MD discusses the now standard of care for all patients diagnosed with a serious cancer to receive care from both an oncologist and a palliative care clinician. She also talks about how she views mentoring as an investment in the future.
- Nov | 26 | 2019
Mass General Cancer Center’s Dr. Jennifer Temel, Clinical Director of Thoracic Oncology, explains what patients can expect during a multidisciplinary appointment.
- Nov | 26 | 2019
Dr. Jennifer Temel, Clinical Director of Thoracic Oncology, sat down with 98.5 The Sports Hub's Bob Socci to discuss a new effort at the Mass General Cancer Center to offer patients who may have a lung cancer diagnosis next day appointments.